Soft Jamb Company – Trademark Portfolio
Entity Type: 19
Soft Jamb Company holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 5 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 3 Nice Classification classes. Currently, 5 trademarks are registered. Notable registered marks include IOMED 35, NAVELDYNE, STICK-IT!, HYDROLINE 34, and SOFT JAMB CO.. The owner is based in Alta Loma, CA.
6298 Mt. Pinos Court
Alta Loma, CA 91737
Showing of trademarks Trademarks
Trademark Classifications
Soft Jamb Company's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does Soft Jamb Company have?
Soft Jamb Company has 9 U.S. trademarks filed with the USPTO. Of these, 5 registered, 4 cancelled.
What trademark classes does Soft Jamb Company file in?
Soft Jamb Company files trademarks across 3 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are Soft Jamb Company's most well-known trademarks?
Soft Jamb Company's registered trademark portfolio includes well-known marks such as IOMED 35, NAVELDYNE, STICK-IT!, HYDROLINE 34, and SOFT JAMB CO.. These are among 5 currently registered trademarks in the portfolio.
What is Soft Jamb Company's trademark registration success rate?
Soft Jamb Company has a 56% trademark registration rate, with 5 out of 9 resolved applications resulting in successful registration. Currently, 0 applications are pending review.